Latvia vs Tunisia: Prevalence of current tobacco use, males
Prevalence of current tobacco use, males over time
- Latvia
- Tunisia
How they compare
Latvia currently reports 47.2% against 46.6% in Tunisia, a difference of 0.6%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Tunisia ahead.
Latvia ranks 21st and Tunisia ranks 23rd of 166 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.4% | 59.3% | 0.1% | Latvia |
| 2010s | 53.8% | 53.5% | 0.2% | Latvia |
| 2020s | 48.1% | 47.7% | 0.4% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, males, Latvia or Tunisia?
- Latvia, at 47.2% against 46.6% in Tunisia as of 2024.
- What is the difference in prevalence of current tobacco use, males between Latvia and Tunisia?
- 0.6%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Tunisia?
- 9 years are reported by both, from 2000 to 2024.
- How do Latvia and Tunisia rank globally for prevalence of current tobacco use, males?
- Latvia ranks 21st and Tunisia ranks 23rd of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use, males (% of male adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.